With the analysis among 3,898 patents, we discovered top 426 key players by total patent application. Smithkline Beckman Corp, Novartis AG, Janssen Pharmaceutica NV are dominant in this area. They take 8.62% of the total patent filing.
Pennsylvania, United States
Patent: 120
Basel-Stadt, Switzerland
Patent: 113
Antwerpen, Belgium
Patent: 103
Cell Signaling Technology, Inc.
Massachusetts, United States
Patent: 101
Illinois, United States
Patent: 92
F. Hoffmann-La Roche Ltd.
Vertex Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 76
Agouron Pharmaceuticals LLC
California, United States
Patent: 76
MethylGene, Inc. (Canada)
New Jersey, United States
Patent: 70
With the analysis among 171 patents, we discovered top 23 start-ups by total patent application. Shenzhen Tajirui Biomedical Co. Ltd., HepaRegeniX GmbH, Institut National de la Santé et de la Recherche Médicale are active in this area.
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 49
Baden-Württemberg, Germany
Patent: 23
Institut National de la Santé et de la Recherche Médicale
Propellon Therapeutics, Inc.
Ontario, Canada
Patent: 15
Argonaut Therapeutics Ltd.
Worg Pharmaceuticals (Zhejiang) Co., Ltd.
Zhejiang Sheng, China
Patent: 7
California, United States
Patent: 7
Corlieve Therapeutics SAS
Aargau, Switzerland
Patent: 5
With the analysis among related 1,141 patents applied in the last 5 years. We discover 378 most active companies in this area. The fast-growing Revolution Medicines, Inc., F. Hoffmann-La Roche Ltd., AbbVie, Inc. take 14.64% of patent filing during this period.
Revolution Medicines, Inc.
California, United States
Patent: 63
F. Hoffmann-La Roche Ltd.
Illinois, United States
Patent: 49
California, United States
Patent: 45
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 39
New Jersey, United States
Patent: 32
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 23
Baden-Württemberg, Germany
Patent: 23
Guangdong Sheng, China
Patent: 19
With the analysis among related 1,141 patents in last 5 years, we discover 222 new entrants. Revolution Medicines, Inc., Calico LLC, HepaRegeniX GmbH are the most active new entrants in this area.
Revolution Medicines, Inc.
California, United States
Patent: 63
California, United States
Patent: 45
Baden-Württemberg, Germany
Patent: 23
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 15
Carmot Therapeutics, Inc.
California, United States
Patent: 13
Argonaut Therapeutics Ltd.
Worg Pharmaceuticals (Zhejiang) Co., Ltd.
Zhejiang Sheng, China
Patent: 7
Texas, United States
Patent: 7
With the analysis among 1,430 patents, we discovered top 223 universities and scientific research institutions by total patent application. Duke University, President & Fellows of Harvard College, Shanghai Institute of Materia Medica Chinese Academy of Sciences are dominant in this area. They take 10.84% of the total patent filing.
North Carolina, United States
Patent: 45
President & Fellows of Harvard College
Massachusetts, United States
Patent: 37
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 35
ZURICH, Switzerland
Patent: 25
Guangdong Sheng, China
Patent: 21
University of Southern California
California, United States
Patent: 19
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 16
The Scripps Research Institute
California, United States
Patent: 16
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 15
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 13